Developer docs
API playgroundTry for free, no card

Search company profiles

Vascutek

Full company profile

uuid0002lga

Namestring
Vascutek
Legal namestring
Vascutek Ltd
Websiteurl
vascutek.com
Company typeenum
Private
Founded yearint
1982
Descriptiontext

Vascutek Ltd, operating commercially under the Terumo Aortic brand, is a UK-based designer and manufacturer of cardiovascular implant devices serving hospitals and vascular/cardiovascular surgeons globally. Founded in 1982 and headquartered in Inchinnan, Renfrewshire, Scotland, the company employs between 501 and 1,000 people and operates as a wholly-owned subsidiary within Terumo Corporation of Japan's aortic care division. Its device portfolio addresses aortic and peripheral vascular disease across the full anatomical range from ascending to descending aorta, with both standard and patient-specific (custom-made) offerings.

The product range combines surgical vascular grafts (Gelweave, Gelsoft Plus, AQUABRID), thoracic and abdominal stent-graft systems (Relay Pro, Relay Plus, TREO), and the Thoraflex Hybrid device that integrates surgical and endovascular techniques for complex aortic repair. A dedicated custom solutions line produces patient-specific implants including Anaconda, Fenestrated TREO, Relay Branch, Relay Proximal Scallop, Relay Multi Feature, and Custom Thoraflex Hybrid for complex anatomical cases. Devices are manufactured at the Inchinnan facility with associated US operations through Bolton Medical Inc. in Sunrise, Florida.

Revenue is generated primarily through direct hardware sales of medical implants to hospitals, with custom devices priced per individual specification. The go-to-market model is enterprise field sales targeting tertiary and quaternary hospitals with cardiovascular surgery and interventional radiology programs, supplemented by clinical training, surgical support, and professional education. The company engages in medical conferences, clinical publications, social media (LinkedIn, X/Twitter), and the Vumedi medical video platform for clinical marketing. Pricing is not publicly disclosed; contracts are typically multi-year. The firm received approximately $45.7 million in funding from Terumo Corporation in February 2018.

Short descriptiontext

Vascutek Ltd (Terumo Aortic) designs and manufactures vascular grafts, stent-graft systems, and hybrid devices for aortic and peripheral vascular disease, selling directly to hospitals and cardiovascular surgeons worldwide from its UK manufacturing base.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
501–1,000
akta.pro rankint
HeadquartersInchinnan, United Kingdom
HQ citystring
Inchinnan
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
vascular grafts, stent-graft systems, aortic implants, cardiovascular devices, endovascular repair
Industry2 codes
1Endovascular Aortic Repair (EVAR/TEVAR) & Aortic Grafts
CodeHLAHAFAFPrimaryYes
2Cardiac Surgery Devices (Cannulas, Clamps, Closure, Grafts)
CodeHLAHAFAHPrimaryNo
NAICS code2 codes
  • Surgical Appliance and Supplies Manufacturing339113
  • Surgical and Medical Instrument Manufacturing339112
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
Product category
Cardiovascular Medical Devices
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Medical Device Sales
TypeHardware Sales
Description

Terumo Aortic generates revenue through the sale of cardiovascular implant devices including stent-grafts, surgical grafts, and custom-made devices to hospitals and healthcare providers globally.

terumoaortic.com
2Custom Solutions
TypeHardware Sales
Description

Revenue from bespoke patient-specific medical devices manufactured to individual anatomical specifications for complex cases.

terumoaortic.com
3Product Support and Training
TypeProfessional Services
Description

Clinical training and product support services for surgeons and hospital staff using the company's devices.

terumoaortic.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Pricing details1 tier
1Standard implant products - pricing not publicly disclosed
ModelOtherBilling cadenceMulti-year contract
Notes

Medical device implants are sold through direct sales to hospitals with quote-based pricing. No public pricing available.

terumoaortic.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Vascutek Ltd, operating as Terumo Aortic, designs and manufactures a comprehensive portfolio of cardiovascular implant devices for the treatment of aortic and peripheral vascular disease. Its offerings include surgical vascular grafts (Gelweave™, Gelsoft™ Plus, AQUABRID™), thoracic and abdominal stent-graft systems (Relay®Pro, Relay®Plus, TREO®), and the Thoraflex™ Hybrid device, along with custom-made patient-specific solutions (Anaconda™, Fenestrated TREO®, Relay®Branch) for complex aortic anatomies.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Reduced bypass time leading to clearer mind and lungs post-surgery
+2 more records
Product overview1 text field

Vascutek operates as the UK entity of Terumo Aortic, a global medical device company specializing in solutions for aortic and peripheral vascular disease. The product portfolio includes a comprehensive range of vascular grafts (Gelweave™, Gelsoft™ Plus, AQUABRID™), thoracic stent-graft systems (Relay®Pro, Relay®Plus), and abdominal stent-graft systems (TREO®), along with the hybrid Thoraflex™ Hybrid device combining surgical and endovascular approaches. Additionally, the company offers custom-made solutions including Anaconda™, Custom TREO®, Fenestrated TREO®, Relay®Branch, Relay® Proximal Scallop, Relay® Multi Feature, and Custom Thoraflex™ Hybrid for patient-specific anatomical requirements. Vascutek manufactures these devices at its facility in Scotland, United Kingdom.

Product and service14 records
1Gelweave™
CategoryVascular Surgical Graft
Description

Woven polyester surgical vascular graft with gelatin sealing technology used in surgical procedures for aortic repair; targeted at cardiovascular surgeons performing open surgical aortic procedures.

2Gelsoft™ Plus
CategoryVascular Surgical Graft
Description

Expanded PTFE (ePTFE) vascular graft for peripheral vascular reconstruction and surgical aortic procedures; used by vascular surgeons for peripheral bypass and reconstruction.

3AQUABRID™
CategoryVascular Surgical Graft
Description

Surgical graft product line for cardiovascular procedures, used in surgical aortic repair for cardiovascular surgeons.

4Relay®Pro Thoracic Stent-graft System
CategoryEndovascular Stent-Graft System
Description

Thoracic stent-graft system for endovascular thoracic aortic repair (TEVAR) delivering proven neurological results; for cardiovascular surgeons and interventional radiologists treating thoracic aortic disease.

5Relay®Plus Thoracic Stent-graft System
CategoryEndovascular Stent-Graft System
Description

Thoracic stent-graft system for endovascular aortic repair; used by cardiovascular surgeons and interventional radiologists for thoracic aortic aneurysm treatment.

6TREO® Abdominal Stent-graft System
CategoryEndovascular Stent-Graft System
Description

Abdominal stent-graft system for EVAR (Endovascular Aneurysm Repair) supporting successful outcomes and aneurysmal sac regression; for vascular surgeons and interventional radiologists treating abdominal aortic aneurysms.

7Thoraflex™ Hybrid
CategoryHybrid Aortic Device
Description

Hybrid device combining surgical and endovascular approaches for complex aortic arch repair, enabling remodelling and aneurysmal regression; for cardiovascular surgeons performing complex aortic procedures.

8Anaconda™ Custom-Made Stent Graft
CategoryCustom Aortic Solution
Description

Custom-made stent graft solution tailored to patient-specific aortic anatomy for complex aortic repair cases; designed for vascular surgeons treating patients with non-standard anatomy.

9Custom TREO®
CategoryCustom Aortic Solution
Description

Customized version of the TREO Abdominal Stent-graft System tailored to individual patient anatomy; used by vascular surgeons and interventional radiologists for patients requiring bespoke EVAR solutions.

10Fenestrated TREO®
CategoryCustom Aortic Solution
Description

Fenestrated configuration of the TREO system for patients with complex aortic anatomy requiring branch vessel preservation; for vascular surgeons and interventional radiologists performing complex EVAR.

11Relay®Branch
CategoryCustom Aortic Solution
Description

Custom branched stent graft for complex aortic dissection involving branch vessels; designed for cardiovascular surgeons treating complex aortic dissection cases.

12Relay® Proximal Scallop (Custom)
CategoryCustom Aortic Solution
Description

Custom proximal scallop configuration for the Relay system to accommodate patient-specific anatomy; for cardiovascular surgeons and interventional radiologists.

13Relay® Multi Feature (Custom)
CategoryCustom Aortic Solution
Description

Custom multi-feature configuration of the Relay stent graft system combining multiple customization features for complex aortic cases; used by cardiovascular surgeons.

14Custom Thoraflex™ Hybrid
CategoryCustom Aortic Solution
Description

Custom-made version of the Thoraflex Hybrid device for patient-specific complex aortic procedures; for cardiovascular surgeons performing complex aortic arch repair.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Abbott's vascular franchise includes endovascular and peripheral vascular devices serving overlapping physician customers; while Abbott focuses on different sub-segments, the broader vascular enterprise context makes it materially comparable to Terumo Aortic.

TypeDirect peer
Description

Prior to its acquisition by Artivion/CryoLife, Jotec was a German-based aortic stent-graft specialist directly comparable to Terumo Aortic's Relay and TREO platforms, particularly in European markets for EVAR/TEVAR procedures.

TypeRegional player
Description

B. Braun's Aesculap division manufactures surgical vascular grafts comparable to Vascutek's Gelweave line, with particularly strong European (especially German) presence — comparable in product category though with geographic emphasis differing from Terumo Aortic's balanced UK/US footing.

TypeBroad incumbent
Description

Global medical device leader with Endurant and Valiant thoracic stent-graft systems directly competing in the EVAR/TEVAR space where Terumo Aortic plays. Comparable as a multi-product aortic franchise targeting vascular surgeons, but operates across a far broader device portfolio.

TypeDirect peer
Description

Cook Medical's Zenith line of aortic stent-grafts is a direct competitor to Terumo Aortic's TREO and Relay platforms, both targeting vascular surgeons performing abdominal and thoracic endovascular aneurysm repair with similar procedural use cases.

TypeDirect peer
Description

Gore's EXCLUDER (abdominal) and TAG (thoracic) stent-graft systems directly compete with Terumo Aortic's TREO and Relay products, and Gore is recognized as a leading aortic repair franchise with strong US market position.

TypeDirect peer
Description

Endologix develops abdominal and thoracic aortic stent-graft systems (e.g., AFX, Alto) and is one of the focused aortic-repair specialists directly comparable to Terumo Aortic in clinical use case and customer base.

TypeDirect peer
Description

Artivion's aortic franchise includes Jotec stent-grafts (acquired in Europe), making it a focused aortic repair specialist with similar product categories (thoracic and abdominal stent-grafts) and European manufacturing presence.

TypeBroad incumbent
Description

Getinge (via Maquet) supplies surgical vascular grafts and cardiovascular surgery products comparable to Vascutek's Gelweave and AQUABRID graft lines, serving overlapping vascular surgery customers in surgical (open) repair settings.

TypeDirect peer
Description

LeMaitre Vascular manufactures vascular grafts and carotid shunts and is a comparable surgical graft specialist serving vascular surgeons — overlapping with Vascutek's surgical graft product lines (Gelweave, Gelsoft Plus).

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Vascutek

Cardiovascular Medical Devicesvascutek.com

Vascutek Ltd (Terumo Aortic) designs and manufactures vascular grafts, stent-graft systems, and hybrid devices for aortic and peripheral vascular disease, selling directly to hospitals and cardiovascular surgeons worldwide from its UK manufacturing base.

What Vascutek does

Vascutek Ltd, operating commercially under the Terumo Aortic brand, is a UK-based designer and manufacturer of cardiovascular implant devices serving hospitals and vascular/cardiovascular surgeons globally. Founded in 1982 and headquartered in Inchinnan, Renfrewshire, Scotland, the company employs between 501 and 1,000 people and operates as a wholly-owned subsidiary within Terumo Corporation of Japan's aortic care division. Its device portfolio addresses aortic and peripheral vascular disease across the full anatomical range from ascending to descending aorta, with both standard and patient-specific (custom-made) offerings.

The product range combines surgical vascular grafts (Gelweave, Gelsoft Plus, AQUABRID), thoracic and abdominal stent-graft systems (Relay Pro, Relay Plus, TREO), and the Thoraflex Hybrid device that integrates surgical and endovascular techniques for complex aortic repair. A dedicated custom solutions line produces patient-specific implants including Anaconda, Fenestrated TREO, Relay Branch, Relay Proximal Scallop, Relay Multi Feature, and Custom Thoraflex Hybrid for complex anatomical cases. Devices are manufactured at the Inchinnan facility with associated US operations through Bolton Medical Inc. in Sunrise, Florida.

Revenue is generated primarily through direct hardware sales of medical implants to hospitals, with custom devices priced per individual specification. The go-to-market model is enterprise field sales targeting tertiary and quaternary hospitals with cardiovascular surgery and interventional radiology programs, supplemented by clinical training, surgical support, and professional education. The company engages in medical conferences, clinical publications, social media (LinkedIn, X/Twitter), and the Vumedi medical video platform for clinical marketing. Pricing is not publicly disclosed; contracts are typically multi-year. The firm received approximately $45.7 million in funding from Terumo Corporation in February 2018.

Vascutek firmographics

Firmographics
Name
Vascutek
Legal name
Vascutek Ltd
Website
https://vascutek.com
Company type
Private
Founded year
1982
Operating status
Operating
Headcount range
501–1,000 employees
Short description
Vascutek Ltd (Terumo Aortic) designs and manufactures vascular grafts, stent-graft systems, and hybrid devices for aortic and peripheral vascular disease, selling directly to hospitals and cardiovascular surgeons worldwide from its UK manufacturing base.
Ownership category
akta.pro rank

Vascutek industry classification

Industry
Product category
Cardiovascular Medical Devices
NAICS
Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112)
SIC
Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
akta.pro primary industry
Endovascular Aortic Repair (EVAR/TEVAR) & Aortic Grafts (HLAHAFAF)
akta.pro secondary industry
Cardiac Surgery Devices (Cannulas, Clamps, Closure, Grafts) (HLAHAFAH)

Keywords

  • Vascular grafts
  • Stent-graft systems
  • Aortic implants
  • Cardiovascular devices
  • Endovascular repair

Where Vascutek is headquartered

Location

Headquarters

HQ city
Inchinnan
HQ country
United Kingdom
HQ region
Europe

Offices2 records

Markets served

Vascutek business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Medical Device Sales: Terumo Aortic generates revenue through the sale of cardiovascular implant devices including stent-grafts, surgical grafts, and custom-made devices to hospitals and healthcare providers globally.
  2. Custom Solutions: Revenue from bespoke patient-specific medical devices manufactured to individual anatomical specifications for complex cases.
  3. Product Support and Training: Clinical training and product support services for surgeons and hospital staff using the company's devices.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractStandard implant products - pricing not publicly disclosed

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Vascutek product offering

Product offering

Core offering

Vascutek Ltd, operating as Terumo Aortic, designs and manufactures a comprehensive portfolio of cardiovascular implant devices for the treatment of aortic and peripheral vascular disease. Its offerings include surgical vascular grafts (Gelweave™, Gelsoft™ Plus, AQUABRID™), thoracic and abdominal stent-graft systems (Relay®Pro, Relay®Plus, TREO®), and the Thoraflex™ Hybrid device, along with custom-made patient-specific solutions (Anaconda™, Fenestrated TREO®, Relay®Branch) for complex aortic anatomies.

Product overview

Vascutek operates as the UK entity of Terumo Aortic, a global medical device company specializing in solutions for aortic and peripheral vascular disease. The product portfolio includes a comprehensive range of vascular grafts (Gelweave™, Gelsoft™ Plus, AQUABRID™), thoracic stent-graft systems (Relay®Pro, Relay®Plus), and abdominal stent-graft systems (TREO®), along with the hybrid Thoraflex™ Hybrid device combining surgical and endovascular approaches. Additionally, the company offers custom-made solutions including Anaconda™, Custom TREO®, Fenestrated TREO®, Relay®Branch, Relay® Proximal Scallop, Relay® Multi Feature, and Custom Thoraflex™ Hybrid for patient-specific anatomical requirements. Vascutek manufactures these devices at its facility in Scotland, United Kingdom.

Differentiator

Problem solved

Functional benefit

Products and services

  • Gelweave™ Woven polyester surgical vascular graft with gelatin sealing technology used in surgical procedures for aortic repair; targeted at cardiovascular surgeons performing open surgical aortic procedures.
  • Gelsoft™ Plus Expanded PTFE (ePTFE) vascular graft for peripheral vascular reconstruction and surgical aortic procedures; used by vascular surgeons for peripheral bypass and reconstruction.
  • AQUABRID™ Surgical graft product line for cardiovascular procedures, used in surgical aortic repair for cardiovascular surgeons.
  • Relay®Pro Thoracic Stent-graft System Thoracic stent-graft system for endovascular thoracic aortic repair (TEVAR) delivering proven neurological results; for cardiovascular surgeons and interventional radiologists treating thoracic aortic disease.
  • Relay®Plus Thoracic Stent-graft System Thoracic stent-graft system for endovascular aortic repair; used by cardiovascular surgeons and interventional radiologists for thoracic aortic aneurysm treatment.
  • TREO® Abdominal Stent-graft System Abdominal stent-graft system for EVAR (Endovascular Aneurysm Repair) supporting successful outcomes and aneurysmal sac regression; for vascular surgeons and interventional radiologists treating abdominal aortic aneurysms.
  • Thoraflex™ Hybrid Hybrid device combining surgical and endovascular approaches for complex aortic arch repair, enabling remodelling and aneurysmal regression; for cardiovascular surgeons performing complex aortic procedures.
  • Anaconda™ Custom-Made Stent Graft Custom-made stent graft solution tailored to patient-specific aortic anatomy for complex aortic repair cases; designed for vascular surgeons treating patients with non-standard anatomy.
  • Custom TREO® Customized version of the TREO Abdominal Stent-graft System tailored to individual patient anatomy; used by vascular surgeons and interventional radiologists for patients requiring bespoke EVAR solutions.
  • Fenestrated TREO® Fenestrated configuration of the TREO system for patients with complex aortic anatomy requiring branch vessel preservation; for vascular surgeons and interventional radiologists performing complex EVAR.
  • Relay®Branch Custom branched stent graft for complex aortic dissection involving branch vessels; designed for cardiovascular surgeons treating complex aortic dissection cases.
  • Relay® Proximal Scallop (Custom) Custom proximal scallop configuration for the Relay system to accommodate patient-specific anatomy; for cardiovascular surgeons and interventional radiologists.
  • Relay® Multi Feature (Custom) Custom multi-feature configuration of the Relay stent graft system combining multiple customization features for complex aortic cases; used by cardiovascular surgeons.
  • Custom Thoraflex™ Hybrid Custom-made version of the Thoraflex Hybrid device for patient-specific complex aortic procedures; for cardiovascular surgeons performing complex aortic arch repair.

Quantifiable outcome

  • Reduced bypass time leading to clearer mind and lungs post-surgery
  • +2 more outcomes

Companies that use Vascutek

Customer profile

Named customers1 record

Segments1 record

Ideal customer profiles1 record

Vascutek technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature7 records

Vascutek partnerships and signals

Strategic signal

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Vascutek competitors and assessment

Company assessment

Broad incumbents

  • Abbott Vascular: Abbott's vascular franchise includes endovascular and peripheral vascular devices serving overlapping physician customers; while Abbott focuses on different sub-segments, the broader vascular enterprise context makes it materially comparable to Terumo Aortic.
  • Medtronic: Global medical device leader with Endurant and Valiant thoracic stent-graft systems directly competing in the EVAR/TEVAR space where Terumo Aortic plays. Comparable as a multi-product aortic franchise targeting vascular surgeons, but operates across a far broader device portfolio.
  • Getinge / Maquet: Getinge (via Maquet) supplies surgical vascular grafts and cardiovascular surgery products comparable to Vascutek's Gelweave and AQUABRID graft lines, serving overlapping vascular surgery customers in surgical (open) repair settings.

Direct peers

  • JOTEC (now Artivion): Prior to its acquisition by Artivion/CryoLife, Jotec was a German-based aortic stent-graft specialist directly comparable to Terumo Aortic's Relay and TREO platforms, particularly in European markets for EVAR/TEVAR procedures.
  • Cook Medical: Cook Medical's Zenith line of aortic stent-grafts is a direct competitor to Terumo Aortic's TREO and Relay platforms, both targeting vascular surgeons performing abdominal and thoracic endovascular aneurysm repair with similar procedural use cases.
  • W. L. Gore & Associates: Gore's EXCLUDER (abdominal) and TAG (thoracic) stent-graft systems directly compete with Terumo Aortic's TREO and Relay products, and Gore is recognized as a leading aortic repair franchise with strong US market position.
  • Endologix: Endologix develops abdominal and thoracic aortic stent-graft systems (e.g., AFX, Alto) and is one of the focused aortic-repair specialists directly comparable to Terumo Aortic in clinical use case and customer base.
  • Artivion (formerly CryoLife): Artivion's aortic franchise includes Jotec stent-grafts (acquired in Europe), making it a focused aortic repair specialist with similar product categories (thoracic and abdominal stent-grafts) and European manufacturing presence.
  • LeMaitre Vascular: LeMaitre Vascular manufactures vascular grafts and carotid shunts and is a comparable surgical graft specialist serving vascular surgeons — overlapping with Vascutek's surgical graft product lines (Gelweave, Gelsoft Plus).

Regional players

  • B. Braun / Aesculap: B. Braun's Aesculap division manufactures surgical vascular grafts comparable to Vascutek's Gelweave line, with particularly strong European (especially German) presence — comparable in product category though with geographic emphasis differing from Terumo Aortic's balanced UK/US footing.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Vascutek social profiles

Digital presence

Vascutek financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Vascutek leadership team

Management profile

Number of profiles

Profiles3 records

Vascutek funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Vascutek M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Vascutek

What does Vascutek do?

Vascutek Ltd, operating as Terumo Aortic, designs and manufactures a comprehensive portfolio of cardiovascular implant devices for the treatment of aortic and peripheral vascular disease. Its offerings include surgical vascular grafts (Gelweave™, Gelsoft™ Plus, AQUABRID™), thoracic and abdominal stent-graft systems (Relay®Pro, Relay®Plus, TREO®), and the Thoraflex™ Hybrid device, along with custom-made patient-specific solutions (Anaconda™, Fenestrated TREO®, Relay®Branch) for complex aortic anatomies.

Is Vascutek a public or private company?

Vascutek is a private company. It is classified as corporate owned and is currently operating.

When was Vascutek founded?

Vascutek was founded in 1982. It employs 501 to 1,000 people.

Where is Vascutek based?

Vascutek is headquartered in Inchinnan, United Kingdom, in the Europe region.

How does Vascutek make money?

Three revenue lines are on record. Medical Device Sales are the primary driver. The others are custom Solutions and product Support and Training.

Who are Vascutek's main competitors?

Broad incumbents on record are Abbott Vascular, Medtronic and Getinge / Maquet. Direct peers are JOTEC (now Artivion), Cook Medical, W. L. Gore & Associates, Endologix, Artivion (formerly CryoLife) and LeMaitre Vascular. B. Braun / Aesculap is listed as a regional player.

Does Vascutek have an API?

No public API is recorded for Vascutek.

What industry is Vascutek in?

Vascutek's product category is Cardiovascular Medical Devices. Its primary akta.pro industry code is HLAHAFAF, Endovascular Aortic Repair (EVAR/TEVAR) & Aortic Grafts, with a secondary code of HLAHAFAH, Cardiac Surgery Devices (Cannulas, Clamps, Closure, Grafts). Its NAICS code is 339113 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PrtimesAortic Aneurysm Market Value: On Track to Cross the $4.5B Threshold – PR TimesA market research report projects the global aortic aneurysm market will grow from USD 2.37 billion in 2024 to USD 4.50 billion by 2032, representing an 8.3% CAGR, driven by a clinical shift from invasive open surgery to minimally invasive endovascular stent-graft procedures. The report highlights corporate consolidation as a key trend, citing Bolton Medical's acquisition of Vascutek to combine aortic and vascular portfolios, while identifying North America as the dominant region and Asia Pacific as a key growth area. Key industry players positioned in this market include Medtronic, W. L. Gore and Associates, Cook, and Terumo Corporation, among others.PR NewswireVascular Grafts Market to Reach US$3.29 Billion by 2024: Demographic Changes Leading to Rise in Geriatric Population to Stoke DemandA Transparency Market Research report projects the global vascular grafts market to grow from US$2.15 billion in 2015 to US$3.29 billion by 2024, representing a compound annual growth rate of 5.0%. The report identifies C.R. Bard, B. Braun Melsungen AG, Vascutek Ltd., MAQUET Holding, Cook Medical, CRYOLIFE, Medtronic, W.L. Gore & Associates, and LeMaitre Vascular as market leaders collectively holding 93.5% of the market in 2016. Rising demand is attributed to increasing lifestyle disorders, an aging population, and favorable reimbursement policies, while regulatory approval complexities and surgical risks present challenges to market growth.